CVS Health Corp Profits and Revenues Top Q4 By

© Reuters.  PGGM Investments reduced stake in CareTrust REIT

© Reuters. CVS Health Corp’s earnings and revenue outperformed in the fourth quarter – CVS Health Corp (NYSE 🙂 reported on Tuesday that the fourth quarter beat analyst forecasts and revenue was above expectations. CVS Health Corp announced earnings per share of $ 1.3 on revenue of $ 69.55B. Analysts surveyed by anticipated EPS of $ 1.24 on revenue of $ 68.73 billion. Shares of CVS Health Corp are up 8% since the beginning of the year, still 3.87% from their 52-week high of $ 77.20 set on January 12. They are outperforming the S&P 500, which is up 4.76% since the beginning of the year. CVS Health Corp follows other major service sector earnings this month CVS Health Corp report follows earnings from on February 2, which reported EPS of $ 14.09 on revenue of $ 125.56B, compared to earnings. EPS forecast of $ 7.2 on revenue of $ 119.72B. Alibaba ADR had beaten expectations on February 2 with a third quarter EPS of $ 22.03 on revenue of $ 221.08B, compared to EPS forecast of $ 20.59 on revenue of $ 214.17B. Stay up-to-date on all upcoming earnings reports by visiting the earnings calendar.

Disclaimer: Fusion Media wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on information, including data, quotes, charts, and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading financial markets, it is one of the riskiest investment forms possible.